TNFi is associated with decreased risk of COVID-19 related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate.”

Published: 12 January 2022| Version 1 | DOI: 10.17632/tvvwmbry4h.1
Contributor:
Rachel Tallman

Description

Supplementary Appendix

Files

Institutions

West Virginia University

Categories

Dermatology

License